Editorial
Abstract
The year begins and our magazine begins 2019 with a large and varied material. The Sixth report of BIOBADASAR, a report of adverse events with biological agents in Argentina, is already a classic in recent years. This registry is of vital importance to understand what happens with these drugs in our country. The current report presents the registry with 4656 patients, 6234 treatments [3765 cases (therapy with biologicals) and 2469 controls (non-biological therapy)].References
-
Copyright (c) 2019 Argentine Journal of Rheumatology

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.